Biosensors Market Size
Biosensors Market Analysis
The Biosensors Market size is estimated at USD 10.97 billion in 2025, and is expected to reach USD 17.11 billion by 2030, at a CAGR of 9.30% during the forecast period (2025-2030).
The biosensor market is growing due to factors such as the increasing prevalence of chronic and lifestyle diseases and the rising demand for point-of-care testing (POCT).
The rising incidence of diabetes, cardiovascular diseases, and cancer is fueling the need for biosensors that monitor glucose levels, heart rate, and biomarkers, which is anticipated to drive the market growth. For instance, according to the data updated by the International Diabetes Federation in January 2025, the organization estimated that a staggering 783 million people, or roughly 1 in 8 adults, will be living with diabetes globally by 2045. Additionally, according to the data published by the British Heart Foundation in September 2024, approximately 620 million individuals were affected by heart and circulatory diseases globally in 2024. Thus, the significant prevalence of these chronic conditions, such as diabetes and heart disorders, is expected to significantly drive the adoption and innovation of biosensors in the market.
The biosensors market has been witnessing significant advancements, driven by the increasing initiatives adopted by the market players. For instance, in September 2024, Monod Bio launched NovoLISA (de Novo protein-Linked Instantaneous Solution-based Assay). This rapid biosensor assay platform delivers results in just 15 minutes, significantly faster than traditional methods like ELISA, commonly used in Research Use Only (RUO) settings. NovoLISA's speed and efficiency stem from combining two proprietary technologies: the LuxSit Pro luciferase reporter and de novo binding protein reagents. Additionally, in January 2023, SCHOTT launched its first United States facility, expanding its capacity to develop and manufacture diagnostic and life science products. The primary focus of this new facility will be the production of custom DNA and protein biosensors. These biosensors will be used to detect and quantify multiple biomarkers associated with infectious diseases, autoimmune disorders, and cancers by targeting genes and proteins of either the infecting agent or those in the affected patient. Such developments underscore the growing innovation and investment in the biosensors market, which is expected to be pivotal in addressing the evolving needs of the healthcare and diagnostics sectors.
Thus, the biosensors market is expanding due to the rising incidence of chronic illnesses and ongoing advancements and investments from market participants. However, the high costs associated with development and production could potentially slow down market growth in the coming years.
Biosensors Market Trends
The Wearable Biosensors Segment is Projected to Hold the Largest Share of the Biosensors Market Throughout the Forecast Period
Wearable biosensors are small, portable devices that can be integrated into clothing, accessories, or attached directly to the body, enabling continuous monitoring of physiological and biochemical parameters, to collect real-time health data. The segment is anticipated to grow due to the growing demands for remote patient monitoring and integration of advanced technologies in wearable biosensors.
The growing adoption of remote healthcare models, particularly for elderly and high-risk patients, is fueling the demand for wearable biosensors. For instance, an article published in the Journal of Applied Sciences in February 2024 mentioned that monitoring heart rate and blood oxygen saturation by using advanced biosensors like the MAX30102 is crucial for evaluating cardiovascular health. These monitors, frequently found in wearable devices, employ photoplethysmography (PPG) sensors that shine light through the skin. Thus, combining these biosensors with multi-hop Internet of Things (IoT) systems is a fundamental advancement in healthcare, especially for real-time remote patient monitoring within hospital settings. Additionally, an article published in JACC Advances in March 2023 stated that researchers utilized a chest-worn biosensor to continuously collect electrocardiographic (ECG) waveforms, 3-axis accelerometry data, skin impedance, skin temperature, and information on activity and posture; collected data was useful in reducing heart failure hospitalization. These advancements underscore wearable biosensors' critical role in transforming healthcare delivery, which is expected to drive significant growth in the studied segment during the forecast period.
The integration of wearable biosensors with artificial intelligence (AI), machine learning, and IoT facilitates predictive analytics and personalized health insights, thus boosts the adoption of these innovative devices. For instance, in December 2024, Proton Intelligence, a Canadian health-tech startup, secured USD 6.95 million in seed funding to develop a potassium monitoring biosensor product. The potassium-monitoring biosensor can be connected to a smartphone app, allowing users to track their potassium levels. The product is expected to have a 2025 launch and is currently undergoing clinical trials. Additionally, in October 2024, STMicroelectronics advanced healthcare wearables by launching its new ST1VAFE3BX bio-sensing chip. This innovative chip integrates high-accuracy biopotential sensing with ST’s established inertial sensing and artificial intelligence (AI) core, enabling advanced activity detection directly on-chip for faster performance and reduced power consumption in devices like smartwatches, sports bands, connected rings, and smart glasses, with applications in heart rate monitoring and cognitive function monitoring, among others. These developments underscore the rapid advancements in the wearable biosensors market, highlighting its potential for significant growth and innovation in the coming years.
In conclusion, the wearable biosensors segment is set to witness significant advancements and adoption, driven by technological innovations, integration with AI and IoT, and the increasing demand for remote healthcare solutions. These factors collectively position wearable biosensors as a critical component in the future of healthcare, offering immense potential for market growth during the forecast period.
The North American market is Expected to Hold the Largest Share of the Biosensors market During the Forecast Period
The North American biosensors market is experiencing growth due to several key factors including a high incidence of chronic diseases, a well-developed healthcare infrastructure, and increasing demand for point-of-care testing, alongside the introduction of advanced new products.
The increasing prevalence of diabetes, cardiovascular diseases, and cancer in the North American region, including the United States and Canada, is fuelling the need for biosensors that enable continuous monitoring and diagnostics. For instance, the data published by the United States Centers for Disease Control and Prevention in November 2024 highlighted that the total prevalence of diabetes among United States adults was 15.8% in 2023. Additionally, according to the data published by the Government of Canada in February 2023, Canada experiences over 106,000 new cases of heart failure every year. This growing prevalence of chronic diseases is expected to significantly contribute to expanding the biosensors market in the region, as biosensors play a critical role in early detection and effective disease management.
The biosensors market has witnessed significant growth, driven by the increasing market player strategies such as product launches and investments. For instance, in August 2024, DexCom, Inc. revealed that its first over-the-counter glucose biosensor Stelo, is available for purchase in the United States without a prescription at Stelo.com. Additionally, in July 2023, VitalConnect, Inc., a provider of wearable biosensor technology for remote and in-hospital use, completed an oversubscribed Series F funding round, securing over USD 30 million. This additional capital will fuel the company's expanding remote cardiac monitoring business and develop strategic partnerships with major United States hospital systems for in-patient remote patient monitoring solutions. These developments highlight the growing innovation and investment in the biosensors market, driven by increasing demand for advanced remote monitoring solutions and over-the-counter accessibility, thus contribute to the market's growth during the forecast period.
Thus, the North American biosensors market is poised for significant growth during the forecast period, fueled by technological advancements, increasing prevalence of chronic diseases, and strategic initiatives by market players. As the demand for efficient and accessible diagnostic tools continues to rise, biosensors are expected to play a pivotal role in shaping the future of healthcare in the region.
Biosensors Industry Overview
The biosensors market is moderately fragmented, with many participants including large multinational companies and smaller, emerging startups. Market players focus on various applications such as glucose monitoring, cardiovascular monitoring and infectious disease detection, among others, creating a diverse market landscape. Key market players include Abbott Laboratories, Medtronic Plc, Dexcom, Inc., F. Hoffmann La Roche Ltd. and Koninklijke Philips N.V., among others.
Biosensors Market Leaders
-
Abbott Laboratories
-
Medtronic Plc
-
Dexcom, Inc.
-
F. Hoffmann La Roche Ltd.
-
Koninklijke Philips N.V.
- *Disclaimer: Major Players sorted in no particular order
Biosensors Market News
- October 2024: Bruker Corporation acquired Dynamic Biosensors GmbH, a Munich-based company in biosensor technology. This acquisition expanded Bruker's biosensors business with enhanced biophysical analysis capabilities, providing enhanced insights into molecular interactions and kinetics, including molecule-cell interactions, for drug discovery and basic research applications.
- April 2024: Biolinq Inc. secured USD 58 million in funding from various investors such as Alpha Wave Ventures and Niterra's corporate venture capital arm (operated with Pegasus Tech Ventures), among others. The funds will be used to complete a critical United States clinical trial for the company's intradermal glucose sensor and to support its subsequent Food and Drug Administration (FDA) submission. The company's user-friendly wearable patch employs a network of miniature electrochemical sensors to measure glucose levels from just below the skin's surface, integrating this glucose data with activity levels in a single device.
Biosensors Industry Segmentation
A biosensor is a tool that uses a biological component like enzymes, antibodies, or DNA to detect and measure specific substances and combines this biological element with a physical or chemical detector. Biosensors are used for diagnosing diseases, tracking health conditions, and managing treatments because they are accurate, fast, and often don't require invasive procedures. The biosensors market is segmented into type, application, technology, end-user and geography. By type, the market is segmented into wearable biosensors and non-wearable biosensors. By application, the market is segmented into diagnostics, therapeutics and patient monitoring. By diagnostics, cancer diagnosis, glucose monitoring, cardiovascular monitoring, infectious disease detection, drug monitoring and other applications (point-of-care testing, personalized medicine and pregnancy testing, among others). By technology, the market is segmented into electrochemical biosensors, optical biosensors, thermal biosensors, piezoelectric biosensors and nanotechnology-based biosensors. By end-user, the market is segmented into hospitals and clinics, home healthcare settings, and other end-users (research institutes and diagnostic laboratories). By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. For each segment, the market size is provided in terms of USD value.
By Type | Wearable Biosensors | ||
Non-Wearable Biosensors | |||
By Application | Cancer Diagnosis | ||
Glucose Monitoring | |||
Cardiovascular Monitoring | |||
Infectious Disease Detection | |||
Drug Monitoring | |||
Other Applications | |||
By Technology | Electrochemical Biosensors | ||
Optical Biosensors | |||
Thermal Biosensors | |||
Piezoelectric Biosensors | |||
Nanotechnology-Based Biosensors | |||
By End-User | Hospitals and Clinics | ||
Home Healthcare Settings | |||
Other End-User | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Wearable Biosensors |
Non-Wearable Biosensors |
Cancer Diagnosis |
Glucose Monitoring |
Cardiovascular Monitoring |
Infectious Disease Detection |
Drug Monitoring |
Other Applications |
Electrochemical Biosensors |
Optical Biosensors |
Thermal Biosensors |
Piezoelectric Biosensors |
Nanotechnology-Based Biosensors |
Hospitals and Clinics |
Home Healthcare Settings |
Other End-User |
North America | United States |
Canada | |
Mexico | |
Europe | Germany |
United Kingdom | |
France | |
Italy | |
Spain | |
Rest of Europe | |
Asia-Pacific | China |
Japan | |
India | |
Australia | |
South Korea | |
Rest of Asia-Pacific | |
Middle East and Africa | GCC |
South Africa | |
Rest of Middle East and Africa | |
South America | Brazil |
Argentina | |
Rest of South America |
Biosensors Market Research FAQs
How big is the Biosensors Market?
The Biosensors Market size is expected to reach USD 10.97 billion in 2025 and grow at a CAGR of 9.30% to reach USD 17.11 billion by 2030.
What is the current Biosensors Market size?
In 2025, the Biosensors Market size is expected to reach USD 10.97 billion.
Who are the key players in Biosensors Market?
Abbott Laboratories, Medtronic Plc, Dexcom, Inc., F. Hoffmann La Roche Ltd. and Koninklijke Philips N.V. are the major companies operating in the Biosensors Market.
Which is the fastest growing region in Biosensors Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Biosensors Market?
In 2025, the North America accounts for the largest market share in Biosensors Market.
What years does this Biosensors Market cover, and what was the market size in 2024?
In 2024, the Biosensors Market size was estimated at USD 9.95 billion. The report covers the Biosensors Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Biosensors Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.